Asterivir develops CD-based broad-spectrum antiviral

New kid on the block: Asterivir’s website has just gone live. Asterivir – a spinout from EPFL (École Polytechnique fédérale de Lausanne) – develops CD-based broad spectrum antivirals lead by Francesco StellacciPaulo Jacob Silva and Oscar Buset. The initial findings of the company were published earlier (Caroline Tapparel Vu et al. )
The website contains nice video graphics of the mechanism of action, which is worth checking!

See the website here

Two papers on the uses of hyper-branched CD-polymer:

Fresh from the oven of the Francesco Trotta and Adrián Matencio Durán (Università degli Studi di Torino) lab, two papers on the uses of hyper-branched CD-polymer:
No 1: use as an anticoagulant, which is a very innovative application for CDs that are getting more and more spotlight

See the full article here

No 2: use as transfection promoters of plasmids.

See the full article here.

I congratulate you on this ambitious research goal, loved both papers and look forward to seeing from sprouting from the collaboration you recently started with CarboHyde!
Yousef Khazaei monfaredMohammad MahmoudianClaudio CeconeFabrizio CalderaSanya HaiatyReza RahbarghaziParvin Zakeri-MilaniGjylije HotiFabrizio CalderaRoberta Cavalli